HWKN

ANALYST NOTE: HWKN (Hawkins, Inc.) Date: 2026-06-13 Analyst: StoryStocks-Native Equity Research

1. Structural Readiness

Current State: Forming

Classification: The setup is FORMING.

• Volatility Context: The current ATR is 3.6%, which falls within the "productive" range (historically 4–6% is the sweet spot, but 3.6% indicates manageable volatility for a mid-cap setup). The ATR at breakout is currently unmeasured as the breakout has not occurred.

2. Thesis Layer

Thesis Status: TACTICAL / SETUP-LED Macro Context: There is NO named secular thesis attached to this name as of 2026-06-13. The investment case is not driven by a specific macro theme (e.g., "Green Energy Transition" or "AI Infrastructure") but is strictly driven by the quality of the technical setup and the underlying business fundamentals. Judgment Criteria: The conviction must be derived solely from the structural integrity of the coil formation and the strength of the company's operational execution, rather than external thematic tailwinds.

3. Business Overview

Company Profile: Hawkins, Inc. is a leading water treatment and specialty ingredients company. As of the latest filings, the company has evolved from a bulk commodity distributor into a specialty ingredients firm. Business Model: The company formulates, manufactures, distributes, and blends products across three primary segments:

• Water Treatment: Provides chemicals, filtration media, systems, and services for potable water, municipal/industrial wastewater, and agricultural water.
• Food and Health Sciences: Delivers ingredient procurement, processing, and formulation for nutrition, food, pharmaceutical, and agricultural markets.
• Industrial Solutions: Supplies industrial chemicals and services to manufacturing, chemical processing, electronics, and energy sectors.

Operational Evidence (Source Dates ≤ 2026-06-13):

• Revenue Growth: The Water Treatment segment sales increased 21% ($20.7 million) year-over-year to $120.5 million for the three months ended December 28, 2025. The Industrial Solutions segment saw a 10% ($4.9 million) increase to $53.6 million in the same period.
• Acquisition Integration: On April 25, 2025, the company acquired WaterSurplus for approximately $149.9 million (plus up to $53.7 million in earnouts). Additionally, aggregate annual revenue from ten businesses acquired in fiscal 2025 and 2026 totaled approximately $116 million.
• Geographic Footprint: The Water Treatment Group operates out of 53 warehouses in 28 states, primarily in the eastern two-thirds of the U.S.
• Seasonality: The Water Treatment Group historically experiences higher sales from April to September due to seasonal demand for municipal water treatment chemicals and pool supplies.
• Customer Concentration: As of the reporting period, no single customer accounted for 10% or more of total sales, indicating a diversified customer base.
• Workforce: Approximately 1,200 employees were employed as of March 29, 2026.

4. Archetype and Conviction

Archetype: Quality Compounder Rationale: The company fits the "Quality Compounder" archetype due to its successful transition from bulk distribution to high-margin specialty ingredients, evidenced by the strategic acquisition of WaterSurplus and the consistent double-digit growth in its Water Treatment segment. The management's focus on "realignment" to reflect value in specialty ingredients supports this classification.

Valuation & Financials:

• Forward Consensus: The financial spine indicates a forward consensus EPS of $3.9345 for FY1 and $4.268 for FY2.
• Liquidity: Management expects cash balances, credit facility availability, and operating cash flows to be sufficient to fund ongoing operations for the foreseeable future. The revolving credit commitment was increased to $400.0 million in April 2025 to support these activities.

Conviction Stack:

• Thesis Strength: Low (Tactical only; no macro tailwind).
• Evidence Quality: High (Strong recent growth data, clear acquisition integration, diversified customer base).
• Setup Readiness: Partial (69% historical breakout probability for this structure).
• Rerating Potential: Dependent on the successful integration of the $116M+ acquired revenue and the realization of the specialty ingredients margin profile.

5. Invalidations, Strengtheners, and Gaps

Invalidation:

• A significant deterioration in the Water Treatment segment growth (e.g., missing the 21% YoY trend) or failure to integrate the WaterSurplus assets would weaken the fundamental thesis.

Strengtheners:

• A daily close above $185.50 would confirm the breakout, converting the setup to "Confirmed-Active."
• Continued sequential growth in the Food and Health Sciences or Industrial Solutions segments would validate the "Quality Compounder" narrative.

Evidence Gaps:

• Margin Data: While revenue growth is cited, specific gross margin or operating margin expansion data post-acquisition is not explicitly detailed in the provided evidence block, though the "specialty ingredients" pivot implies margin improvement.
• Debt Service: While liquidity is described as sufficient, specific details on debt service coverage ratios post-$150M acquisition are not provided in the current evidence set.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key risks: Breakout failure at $185.50 resistance; integration risks from recent M&A activity; lack of named secular thesis to provide macro tailwinds. Sizing hint: Position size should reflect the "forming" nature of the setup; treat as a partial conviction play rather than a full allocation until breakout confirmation. Expected path: Management expects continued operational funding via existing credit facilities and cash flows; structural implication is a potential re-rating if the specialty ingredients pivot continues to drive revenue growth. Expected horizon: 3 to 6 months for the coil structure to resolve (breakout or invalidation). Failure mode to watch: A daily close below $144.95, which would signal the coil structure has failed and the setup is invalidated.